Response to Salvage Therapy, The Main Prognosis Factor in Patients with Refractory or Relapsed Diffuse Large B-Cell Lymphoma Treated with R-ESHAP and Autologous Stem Cell Transplantation

被引：0
|
作者：
Salido Toimil, F. [1 ]
Torres Carrete, P. [1 ]
Deben Ariznavarreta, G. [1 ]
Varela Gomez, M. R. [1 ]
Lopez Fernandez, M. F. [1 ]
Noriega Concepcion, V. [1 ]
机构：
[1] Complexo Hosp Univ A Coruna, La Coruna, Spain
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P352
引用
收藏
页码：S300 / S301
页数：2
相关论文
共 50 条
  • [31] Autologous Stem Cell Transplant in Fit Patients With Late Relapsed Diffuse Large B-Cell Lymphoma That Responded to Salvage Chemotherapy
    Tun, Aung M.
    Wang, Yucai
    Maliske, Seth
    Micallef, Ivana
    Inwards, David J.
    Habermann, Thomas M.
    Porrata, Luis
    Paludo, Jonas
    Bisneto, Jose Villasboas
    Rosenthal, Allison
    Kharfan-Dabaja, Mohamed A.
    Ansell, Stephen M.
    Nowakowski, Grzegorz S.
    Farooq, Umar
    Johnston, Patrick B.
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (10): : 1001e1 - 1001e12
  • [32] Outcomes of allogeneic hematopoietic stem cell transplantation for relapsed or refractory diffuse large B-cell lymphoma
    Koji Kato
    Takeshi Sugio
    Takashi Ikeda
    Kanako Yoshitsugu
    Kana Miyazaki
    Junji Suzumiya
    Go Yamamoto
    Sung-Won Kim
    Kazuhiro Ikegame
    Yasufumi Uehara
    Yasuo Mori
    Jun Ishikawa
    Nobuhiro Hiramoto
    Tetsuya Eto
    Hideyuki Nakazawa
    Hikaru Kobayashi
    Kentaro Serizawa
    Makoto Onizuka
    Takahiro Fukuda
    Yoshiko Atsuta
    Ritsuro Suzuki
    Bone Marrow Transplantation, 2024, 59 : 306 - 314
  • [33] The efficacy and safety of autologous stem cell transplantation in relapsed chemosensitive and chemoresistant patients with diffuse large B-cell lymphoma
    Armatys, A.
    Wieczorkiewicz-Kabut, A.
    Panz-Klapuch, M.
    Koclega, A.
    Kopinska, A. J.
    Kata, D.
    Wozniczka, K.
    Helbig, G.
    NEOPLASMA, 2020, 67 (06) : 1431 - 1436
  • [34] Role of Consolidative Radiation Therapy Following Autologous Stem Cell Transplant for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Coutu, B. G.
    Wilke, C. T.
    Yuan, J.
    Cao, Q.
    Vernon, M. R.
    Lee, C. K.
    Dusenbery, K. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S66 - S66
  • [35] SALVAGE TREATMENT WITH R-IEV (RITUXIMAB, IFOSFAMIDE, EPIRUBICIN, ETOPOSIDE) AND AUTOLOGOUS STEM CELL TRANSPLANT FOR RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
    Gumenyuk, S.
    Marchesi, F.
    Borza, P. Anticoli
    Renzi, D.
    Palombi, F.
    Pisani, F.
    Romano, A.
    Spadea, A.
    Canfora, M.
    Papa, E.
    Mengarelli, A.
    HAEMATOLOGICA, 2016, 101 : 685 - 686
  • [36] Outcomes of salvage chemotherapy and autologous stem cell transplantation for relapsed or refractory primary mediastinal large B cell lymphoma (PMLCL) are inferior to diffuse large B cell lymphoma (DLBCL).
    Kuruvilla, J
    Nagy, T
    Pintilie, M
    Keating, A
    Crump, M
    BLOOD, 2005, 106 (11) : 590A - 590A
  • [37] ESHAP Versus Rituximab-ESHAP in Frail Patients With Refractory Diffuse Large B-Cell Lymphoma
    Aviles, Agustin
    Neri, Natividad
    Huerta-Guzman, Judith
    de Jesus Nambo, Maria
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (02): : 125 - 128
  • [38] Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma
    Kewalramani, T
    Zelenetz, AD
    Nimer, SD
    Portlock, C
    Straus, D
    Noy, A
    O'Connor, O
    Filippa, DA
    Teruya-Feldstein, J
    Gencarelli, A
    Qin, J
    Waxman, A
    Yahalom, J
    Moskowitz, CH
    BLOOD, 2004, 103 (10) : 3684 - 3688
  • [39] Autologous Hematopoietic Stem Cell Transplantation for Diffuse Large B-Cell Lymphoma
    Kondo, Eisei
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2016, 56 (02) : 100 - 108
  • [40] Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?
    Struessmann, Tim
    Marks, Reinhard
    Waesch, Ralph
    CANCERS, 2024, 16 (11)
12345